IS2174B - Setnar fenýl-píperasín afleiður, framleiðsla þeirra og notkun - Google Patents

Setnar fenýl-píperasín afleiður, framleiðsla þeirra og notkun

Info

Publication number
IS2174B
IS2174B IS6420A IS6420A IS2174B IS 2174 B IS2174 B IS 2174B IS 6420 A IS6420 A IS 6420A IS 6420 A IS6420 A IS 6420A IS 2174 B IS2174 B IS 2174B
Authority
IS
Iceland
Prior art keywords
establishes
phenyl
production
piperazine derivatives
piperazine
Prior art date
Application number
IS6420A
Other languages
English (en)
Other versions
IS6420A (is
Inventor
Ruhland Thomas
Krog-Jensen Christian
Rottländer Mario
Mikkelsen Gitte
Knud Moltzen Ejner
Andersen Kim
Original Assignee
H. Lundbeck A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by H. Lundbeck A/S filed Critical H. Lundbeck A/S
Publication of IS6420A publication Critical patent/IS6420A/is
Publication of IS2174B publication Critical patent/IS2174B/is

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IS6420A 1999-12-30 2002-06-13 Setnar fenýl-píperasín afleiður, framleiðsla þeirra og notkun IS2174B (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA199901885 1999-12-30
PCT/DK2000/000721 WO2001049678A1 (en) 1999-12-30 2000-12-20 Substituted phenyl-piperazine derivatives, their preparation and use

Publications (2)

Publication Number Publication Date
IS6420A IS6420A (is) 2002-06-13
IS2174B true IS2174B (is) 2006-11-15

Family

ID=8108803

Family Applications (1)

Application Number Title Priority Date Filing Date
IS6420A IS2174B (is) 1999-12-30 2002-06-13 Setnar fenýl-píperasín afleiður, framleiðsla þeirra og notkun

Country Status (28)

Country Link
US (1) US6699864B2 (is)
EP (1) EP1246816B1 (is)
JP (1) JP2003519224A (is)
KR (1) KR100790916B1 (is)
CN (1) CN1230432C (is)
AR (1) AR029428A1 (is)
AT (1) ATE261959T1 (is)
AU (1) AU2152101A (is)
BG (1) BG65262B1 (is)
BR (1) BR0016952A (is)
CA (1) CA2395705C (is)
CZ (1) CZ20022319A3 (is)
DE (1) DE60009155T2 (is)
EA (1) EA006071B1 (is)
ES (1) ES2213634T3 (is)
HU (1) HUP0203722A3 (is)
IL (2) IL150241A0 (is)
IS (1) IS2174B (is)
MX (1) MXPA02006223A (is)
NO (1) NO322666B1 (is)
NZ (1) NZ519647A (is)
PL (1) PL199351B1 (is)
PT (1) PT1246816E (is)
SK (1) SK9442002A3 (is)
TR (2) TR200400645T4 (is)
UA (1) UA72948C2 (is)
WO (1) WO2001049678A1 (is)
ZA (1) ZA200204814B (is)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA81749C2 (uk) * 2001-10-04 2008-02-11 Х. Луннбек А/С Фенілпіперазинові похідні як інгібітори зворотного захоплення серотоніну
DE10259244A1 (de) * 2002-12-17 2004-07-01 Merck Patent Gmbh N-(Indolethyl-)cycloamin-Verbindungen
UA81300C2 (en) * 2003-04-04 2007-12-25 Lundbeck & Co As H Derivates of 4-(2-fenilsulfanilfenil)-1,2,3,6-tetrahydropiridin as retarding agents of serotonin recapture
WO2004087156A1 (en) 2003-04-04 2004-10-14 H. Lundbeck A/S 4-(2-phenylsulfanyl-phenyl)-piperidine derivatives as serotonin reuptake inhibitors
EP1701940B1 (en) 2003-12-23 2008-05-28 H.Lundbeck A/S 2-(1h-indolylsulfanyl)-benzyl amine derivatives as ssri
SE0400441D0 (sv) 2004-02-25 2004-02-25 Active Biotech Ab Novel Benzofurans and Indols
AR052308A1 (es) 2004-07-16 2007-03-14 Lundbeck & Co As H Derivados de 2-(1h-indolilsulfanil)-arilamina y una composicion farmaceutica que contiene al compuesto
US7629473B2 (en) 2005-06-17 2009-12-08 H. Lundbeck A/S 2-(1H-indolylsulfanyl)-aryl amine derivatives
AR054393A1 (es) 2005-06-17 2007-06-20 Lundbeck & Co As H Derivados de benzo(b)furano y benzo(b)tiofeno, composiciones farmaceuticas que los contienen y su uso en la fabricacion de un medicamento para el tratamiento de enfermedades mediadas por la inhibicion de la reabsorcion de neurotransmisores de amina biogenicos.
MY150647A (en) 2006-06-16 2014-02-14 Lundbeck & Co As H 1-[2-(2,4-dimethylphenylsulfanyl)-phenyl] piperazine as a compound with combined serotonin reuptake, 5-ht3 and 5-ht1a activity for the treatment of cognitive impairment
EP2209380A4 (en) * 2007-10-09 2011-09-14 Mark T Hamann METHOD OF USE OF COMPOSITIONS WITH ANTIDEPRESSIVE EFFICACY, MOOD EFFICACY AND OTHER NEUROLOGICAL EFFECTIVENESS AND COMPOSITIONS THEREOF
WO2009112139A1 (en) * 2008-03-14 2009-09-17 Merck Patent Gmbh, Azaindole compounds for treatment of central nervous system disorders
CN105283442B (zh) * 2013-04-04 2018-04-13 斯洛文尼亚莱柯制药股份有限公司 用于合成1‑(2‑((2,4‑二甲基苯基)硫代)苯基)哌嗪的方法
WO2015169180A1 (en) * 2014-05-04 2015-11-12 Sunshine Lake Pharma Co., Ltd. Substituted piperazine compounds and methods and use thereof
CN105085491B (zh) * 2014-05-05 2019-06-25 广东东阳光药业有限公司 取代的吲哚化合物及其使用方法和用途
CN106243088B (zh) 2015-06-03 2019-01-04 广东东阳光药业有限公司 取代的哌嗪化合物及其使用方法和用途
WO2017012579A1 (zh) * 2015-07-23 2017-01-26 广东东阳光药业有限公司 取代的吲哚化合物及其使用方法和用途
US11285153B2 (en) 2017-09-29 2022-03-29 Sunshine Lake Pharma Co., Ltd. Substituted pyrimidine piperazine compound and use thereof
CN111518012A (zh) * 2020-05-27 2020-08-11 中国药科大学 含苯硫醚结构的化合物或其药学上可接受的盐、制备方法和用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2138865A1 (de) * 1970-08-15 1973-02-22 Sumitomo Chemical Co 3-indolylpiperazine, verfahren zu ihrer herstellung und arzneimittel
GB8830312D0 (en) * 1988-12-28 1989-02-22 Lundbeck & Co As H Heterocyclic compounds
AU6435594A (en) * 1993-04-15 1994-11-08 Merck Sharp & Dohme Limited Indole derivatives as dopamine d4 antagonists
FR2712591B1 (fr) * 1993-11-19 1996-02-09 Pf Medicament Nouvelles arylpipérazines dérivées d'indole, leur préparation et leur utilisation thérapeutique.
WO1997019039A1 (en) 1995-11-17 1997-05-29 Novartis Ag Solid phase synthesis of heterocyclic compounds and combinatorial compound library
USH2007H1 (en) * 1996-01-19 2001-12-04 Fmc Corporation Insecticidal N-heterocyclylalkyl-or N-[(polycyclyl)alkyl]-N′substituted piperazines
ES2128266B1 (es) * 1997-07-08 2000-01-16 Vita Invest Sa Compuestos derivados de tiofeno y benzotiofeno y utilizacion y composicion correspondientes.
DE60034571T2 (de) 1999-06-15 2007-12-27 Aventis Pharmaceuticals Inc. Festphasensynthese von n,n-disubstituierten diazacycloalkylcarboxy-derivaten
JP2003519227A (ja) * 1999-12-30 2003-06-17 ハー・ルンドベック・アクチエゼルスカベット 置換されたベンゼン誘導体の製造方法

Also Published As

Publication number Publication date
HUP0203722A3 (en) 2005-03-29
ZA200204814B (en) 2003-08-27
EP1246816B1 (en) 2004-03-17
IS6420A (is) 2002-06-13
SK9442002A3 (en) 2002-11-06
PT1246816E (pt) 2004-08-31
JP2003519224A (ja) 2003-06-17
ES2213634T3 (es) 2004-09-01
US20030125320A1 (en) 2003-07-03
PL199351B1 (pl) 2008-09-30
BG65262B1 (bg) 2007-10-31
AU2152101A (en) 2001-07-16
NO322666B1 (no) 2006-11-13
ATE261959T1 (de) 2004-04-15
TR200201683T2 (tr) 2002-12-23
NZ519647A (en) 2004-02-27
EP1246816A1 (en) 2002-10-09
WO2001049678A1 (en) 2001-07-12
CA2395705A1 (en) 2001-07-12
CN1437597A (zh) 2003-08-20
US6699864B2 (en) 2004-03-02
EA200200732A1 (ru) 2003-02-27
EA006071B1 (ru) 2005-08-25
BG106930A (en) 2003-04-30
DE60009155D1 (de) 2004-04-22
BR0016952A (pt) 2002-10-08
PL355539A1 (en) 2004-05-04
CZ20022319A3 (cs) 2002-10-16
KR100790916B1 (ko) 2008-01-03
MXPA02006223A (es) 2002-12-05
UA72948C2 (uk) 2005-05-16
AR029428A1 (es) 2003-06-25
IL150241A (en) 2008-12-29
NO20023146L (no) 2002-06-28
HUP0203722A2 (hu) 2003-03-28
TR200400645T4 (tr) 2004-06-21
KR20020063287A (ko) 2002-08-01
IL150241A0 (en) 2002-12-01
CA2395705C (en) 2006-10-17
WO2001049678A9 (en) 2002-10-10
DE60009155T2 (de) 2005-01-05
CN1230432C (zh) 2005-12-07
NO20023146D0 (no) 2002-06-28

Similar Documents

Publication Publication Date Title
IS2215B (is) Setnar fenýlafleiður, framleiðsla þeirra og notkun
NO20021449D0 (no) Substituerte 2-tio-3,5-dicyano-4-aryl-6-aminopyridiner og anvendelse derav
IS2040B (is) Pýrasólínafleiður, framleiðsla þeirra og notkun sem lyfja
NO20012567D0 (no) Azepinoindolderivater, fremstilling og anvendelse derav
IS6385A (is) Ný notkun og nýjar N-asabísýkló-amíð afleiður
NO20021379D0 (no) Benzodiazepin-derivater, fremstilling og anvendelse derav
IS5983A (is) Píperidín, tetrahýdrópýridín og píperzín afleiður, framleiðsla þeirra og notkun
NO20052855D0 (no) Fosfonoksykinazolinderivater og farmasoytisk anvendelse derav.
DK1180518T3 (da) 5-pyridyl-1,3-azolforbindelser, fremgangsmåde til fremstilling deraf og anvendelse deraf
IS5353A (is) Asýl-píperasínil-pýrimídínafleiður, framleiðsla og notkun þeirra sem lyfja
IS6420A (is) Setnar Fenýl-píperazín afleiður, framleiðsla þeirra og notkun
IS7829A (is) Nýjar 1,4-díazabísýklóalkan-afleiður, framleiðslaþeirra og notkun
DK1043307T3 (da) 3-amino-3-arylpropan-1-ol-derivater, deres fremstilling og anvendelse
DK1202996T3 (da) Titanforbindelser, fremstilling og anvendelse heraf
DK1334106T3 (da) Imidazolderivater, fremstillingsmetoder deraf og anvendelse deraf
ATE505459T1 (de) Dibenzoäb,füazepin-derivate und ihre herstellung
IS8383A (is) Nýjar afleiður af 4a,5,9,10,11,12-hexahýdróbensófúró[3a,3,2][2]-bensasepín, aðferð við framleiðslu þeirra og notkun þeirra við framleiðslu á lyfjum
IS5940A (is) Bensófúran afleiður, framleiðsla þeirra og notkun
IS6403A (is) Nýjar heteróarýl afleiður, framleiðsla þeirra og notkun
IS2487B (is) Asýloxýpýrrólidín afleiður, framleiðsla og meðferðarnotkun þar á
HU0001397D0 (en) 3-amino-3-arylpropan-1-ol derivatives, production and use thereof
NO20022482L (no) 2-arylkinolinderivater, fremgangsmåte og terapeutisk anvendelse derav
PT1235809E (pt) 1,2,3,4,5,6-hexa-hidro-2,6-metano-3-benzazocinas substituidas e sua utilizacao como medicamentos
DK1107793T3 (da) Dextran-leptin-konjugater, farmaceutiske præparater og relaterede fremgangsmåder
SI1246816T1 (en) Substituted phenyl-piperazine derivatives, their preparation and use